Here's Why Coherus Biosciences Rose Over 21% Today

Shares of Coherus Biosciences (NASDAQ: CHRS) are soaring higher today after the biopharma company disclosed through an SEC filing that it's one step closer to receiving marketing approval in the European Union for its first clinical product.At the Committee for Medicinal Products for Human Use (CHMP) meeting in June, regulators raised several questions about the company's lead drug candidate, CHS-1701.

BING NEWS:
  • Coherus BioSciences to divest UDENYCA franchise for up to $558.4M
    Coherus BioSciences (NASDAQ ... of the UDENYCA franchise for up to $558.4 million. Shares of the firm rose 27.7% in premarket trade. The deal price includes an upfront payment of $483.4 million ...
    12/6/2024 - 8:32 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News